177
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE
“
MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS
”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
CONTENT ANALYSIS OF THE RANGE OF ANTIALLERGIC DRUGS IN THE
REPUBLIC OF UZBEKISTAN FOR 2021-2025
Akramov U.Dj.
Abdullayeva X.K.
Tashkent Pharmaceutical Institute, Tashkent city, Republic of Uzbekistan
e-mail: akramov.ubaydulla@gmail.com
https://doi.org/10.5281/zenodo.17332503
Relevance:
currently, the prevalence of allergic diseases is constantly increasing. Allergic
diseases and their complications lead to a decrease in the quality of life and an increase in the need
for anti-allergic drugs. In this regard, there is a need to study the pharmaceutical market of antiallergic
drugs, which will allow us to determine how modern the range of this group of drugs is in the Republic
of Uzbekistan.
Purpose of the study:
the purpose of our work was to analyze anti-allergic drugs in the
pharmaceutical market of Uzbekistan for 2021-2025.
Materials and methods:
the materials of this study were the State Registers of drugs and
medical equipment registered in the Republic of Uzbekistan for 2021-2025 (No. 25-29), which were
subjected to content analysis.
Results:
in Uzbekistan in 2021, 210 trade names of anti-allergic drugs were registered, among
which 30.95% of domestic, 51.90% of imported production and 17.14% of production of CIS
countries. In 2022, 206 trade names of anti-allergic drugs were registered, among which 29.12% of
domestic, 53.88% of imported production and 16.99% of production of CIS countries. In 2023, 201
trade names of anti-allergic drugs were registered, including 31.80% of domestic, 52.30% of imported
production and 15.90% of production of CIS countries. In 2024, 213 trade names of anti-allergic
drugs were registered, including 33.90% of domestic, 48.80% of imported production and 17.20% of
production of CIS countries. According to the results of the analysis, it was found that the range of
antiallergic drugs as a whole has increased. In 2024, 219 trade names of anti-allergic drugs were
registered, including 35.19% of domestic, 51.10% of imported production and 13.71% of production
of CIS countries. According to the results of the analysis, it was found that the range of antiallergic
drugs as a whole has increased:
Years
The general range of
anti-allergic drugs
Anti-allergic drugs of manufacturers of
Uzbekistan
CIS countries Foreign countries
2021
210
65
36
109
2022
206
60
35
111
2023
201
62
36
103
2024
213
72
35
96
2025
219
77
30
112
A comparative analysis of the range of anti-allergic drugs by producing countries was also
carried out. The data obtained indicate that anti-allergic drugs are presented in a wide range. Based
on the results of the analysis, it was found that the largest number of antiallergic drugs falls on the
share of Uzbekistan (41.91%), then India (20.66%), Turkey (8.10%), Russia (6.40%) and Ukraine
(5.65%).
178
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE
“
MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS
”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
Conclusions:
during the research period, there was a tendency to increase the number and share
of trade names of anti-allergic drugs of foreign and domestic production. The increase in the number
of anti-allergic drugs of domestic production in the pharmaceutical market of Uzbekistan is of great
social and economic importance.
